I am biased because I own some for a swing trade :P But the rationale is essentially that they will announce their Pre-NDA meeting with the FDA outcome, and I think the FDA will allow them to file for hematide in the dialysis setting (70%) of the market.
The 10-Q out today said something along those lines. Personally, I think they have already had the FDA meeting, and are very close to announcing those results, which I am hoping is monday (lol)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.